"Doporu\u010Duje se pe\u010Dliv\u00E9 klinick\u00E9 monitorov\u00E1n\u00ED (viz 4.2 D\u00E1vkov\u00E1n\u00ED a zp\u016Fsob pod\u00E1n\u00ED: Star\u0161\u00ED pacienti a 5.2 Farmakokinetick\u00E9 vlastnosti: Star\u0161\u00ED pacienti)."@cs . . "22251"^^ . "2"^^ . "22103"^^ . . .